✦ LIBER ✦

RE: Ocular treatment of diabetic macular edema in Canada: where are we going?

✍ Scribed by Noble, Jason; Kertes, Peter J.

Book ID: 122775085
Publisher: Canadian Ophthalmological Society
Year: 2011
Tongue: English
Weight: 115 KB
Volume: 46
Category: Article
ISSN: 0008-4182
DOI: 10.1016/j.jcjo.2011.10.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ocular treatment of diabetic macular ede

Ocular treatment of diabetic macular edema in Canada: where are we going?

✍ Tennant, Matthew T.S. 📂 Article 📅 2011 🏛 Canadian Ophthalmological Society 🌐 English ⚖ 139 KB

PDB32 ECONOMIC EVALUATION OF RANIBIZUMAB

PDB32 ECONOMIC EVALUATION OF RANIBIZUMAB FOR THE TREATMENT OF DIABETIC MACULAR EDEMA IN CANADA

✍ J. Haig; D. Lawrence; M. Barbeau; J. Blouin; A. Cruess 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB

What have we learned and where are we go

What have we learned and where are we going in the treatment of colorectal and gastric cancer?

✍ E. Van Cutsem; E. Diaz-Rubio; H. Wilke 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Examples of implementation and evaluatio

Examples of implementation and evaluation of treatment fidelity in the BCC studies: Where we are and where we need to go

✍ Barbara Resnick; Albert J. Bellg; Belinda Borrelli; Carol De Francesco; Rosemary 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 83 KB

Discussion: Newer bisphosphonates in the

Discussion: Newer bisphosphonates in the treatment of paget's disease of bone: Where we are and where we want to go

✍ Andreas Grauer; Henry Bone; Eugene V. Mccloskey; Michael Mcclung; Donald H. Gutt 📂 Article 📅 1999 🏛 American Society for Bone and Mineral Research 🌐 English ⚖ 569 KB

Aldose reductase inhibition in the treat

Aldose reductase inhibition in the treatment of diabetic neuropathy: Where are we in 2004?

✍ Kenneth H. Gabbay 📂 Article 📅 2004 🏛 Current Science Inc. 🌐 English ⚖ 177 KB